A pilot study to assess the feasibility of a prospective randomised controlled trial of a patient-centred medicines management approach to reduce the burden of iatrogenic symptoms in palliative care
Completed
- Conditions
- All patients referred to pallaitive care, irrespective of underlying diagnosis.Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)
- Registration Number
- ACTRN12611001262998
- Lead Sponsor
- Flinders University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Greater thant 18 years of age
Able to give written informed consent
Able to keep a diary of events
English-speaking and able to read questionnaires
Exclusion Criteria
Patients unable to give consent or those who are deemed inappropriate to participate in the interview by the palliative care team.
Clinical prediction of survival < 6 weeks.
Australian Karnofsky Performance Status score (AKPS) is = 40 at the time of referral
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The total number of patient defined adverse events between enrolment in the study and either loss of cognition or death.[Loss of cognition, death or study end, whichever is first.]
- Secondary Outcome Measures
Name Time Method